Ray Sumita — SEC insider filings

SEC reporting owner CIK 1579629. 16 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2021-01-22 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cue Biopharma, Inc. (CUE)Chief Legal Compliance Officer3—4 legs · 10,673 sh · $317,3524
Biomea Fusion, Inc. (BMEA)Director7——7
Calithera Biosciences, Inc. (CALA)See Remarks4——6
Instil Bio, Inc. (TIL)Chief Legal and Admin Officer1——2
Vaxxinity, Inc. (VAXX)Chief Legal, Comp & Admin Off1——1

Insider filings — Ray Sumita

FiledFormIssuerReported transactionsSource
2026-10-144Cue Biopharma, Inc. (CUE)Sale (S): 1,844 @ $28.05EDGAR
2026-08-174Cue Biopharma, Inc. (CUE)Option exercise (M): 18,196 @ $0 · Sale (S): 2,383 @ $29.37 · Sale (S): 6,442 @ $30.35 · Sale (S): 4 @ $31.13 · Option exercise (M): 18,196 (derivative) @ $0EDGAR
2026-07-104Cue Biopharma, Inc. (CUE)Grant/award (A): 54,589 @ $0 · Grant/award (A): 54,589 (derivative) @ $0EDGAR
2026-06-124Biomea Fusion, Inc. (BMEA)Grant/award (A): 196,299 (derivative) @ $0EDGAR
2025-06-134Biomea Fusion, Inc. (BMEA)Grant/award (A): 91,970 (derivative) @ $0EDGAR
2024-06-134Biomea Fusion, Inc. (BMEA)Grant/award (A): 51,025 (derivative) @ $0EDGAR
2024-04-294Vaxxinity, Inc. (VAXX)Grant/award (A): 425,000 (derivative) @ $0EDGAR
2023-06-164Biomea Fusion, Inc. (BMEA)Grant/award (A): 6,989 (derivative) @ $0EDGAR
2023-01-204Instil Bio, Inc. (TIL)Grant/award (A): 415,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-06-244Biomea Fusion, Inc. (BMEA)Grant/award (A): 23,867 (derivative) @ $0EDGAR
2022-03-074Biomea Fusion, Inc. (BMEA)Grant/award (A): 21,461 (derivative) @ $0EDGAR
2022-01-274Calithera Biosciences, Inc. (CALA)Grant/award (A): 165,000 (derivative) @ $0EDGAR
2021-11-094Calithera Biosciences, Inc. (CALA)Grant/award (A): 12,000 @ $0EDGAR
2021-10-294Calithera Biosciences, Inc. (CALA)Grant/award (A): 36,000 @ $0EDGAR
2021-06-214Biomea Fusion, Inc. (BMEA)Grant/award (A): 17,724 (derivative) @ $0EDGAR
2021-01-224Calithera Biosciences, Inc. (CALA)Grant/award (A): 30,000 @ $0 · Grant/award (A): 12,000 @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579629 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs